| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/14/2023 | BioXcel Therapeutics, Inc. | BTAI | Exercise | Restricted Stock Units | 521 | $0.00 | $0 | | 06/14/2023 |
| 05/15/2023 | BioXcel Therapeutics, Inc. | BTAI | Sale | Common Stock | 5k | $27.17 | $135.9k | | 05/14/2023 |
| 05/14/2023 | BioXcel Therapeutics, Inc. | BTAI | Exercise | Restricted Stock Units | 5k | $0.00 | $0 | | 05/14/2023 |
| 05/04/2023 | ATOSSA THERAPEUTICS, INC. | ATOS | Grant | Stock Option (right to buy) | 125k | $0.66 | $82.8k | | 05/04/2023 |
| 03/15/2023 | BioXcel Therapeutics, Inc. | BTAI | Sale | Common Stock | 2.1k | $19.50 | $40.6k | | 03/14/2023 |
| 03/15/2023 | BioXcel Therapeutics, Inc. | BTAI | Grant | Restricted Stock Units | 9k | $0.00 | $0 | | 03/14/2023 |
| 03/15/2023 | BioXcel Therapeutics, Inc. | BTAI | Grant | Stock Option (Right to Buy) | 32k | $19.60 | $627.2k | | 03/14/2023 |
| 03/14/2023 | BioXcel Therapeutics, Inc. | BTAI | Exercise | Restricted Stock Units | 2.1k | $0.00 | $0 | | 03/14/2023 |
| 07/01/2022 | Actinium Pharmaceuticals, Inc. | ATNM | Grant | Stock Option (Right to Buy) | 72.2k | $0.00 | $0 | | 07/01/2022 |
| 05/14/2022 | BioXcel Therapeutics, Inc. | BTAI | Grant | Restricted Stock Units | 5k | $0.00 | $0 | | 05/14/2022 |
| 05/13/2022 | ATOSSA THERAPEUTICS, INC. | ATOS | Grant | Stock Option (right to buy) | 50k | $0.93 | $46.5k | | 05/13/2022 |
| 03/14/2022 | BioXcel Therapeutics, Inc. | BTAI | Grant | Restricted Stock Units | 8.3k | $0.00 | $0 | | 03/14/2022 |
| 03/14/2022 | BioXcel Therapeutics, Inc. | BTAI | Grant | Stock Option (Right to Buy) | 33.4k | $15.31 | $510.6k | | 03/14/2022 |
| 09/01/2021 | Actinium Pharmaceuticals, Inc. | ATNM | Grant | Stock Option (Right to Buy) | 18.4k | $0.00 | $0 | | 09/01/2021 |
| 05/14/2021 | ATOSSA THERAPEUTICS, INC. | ATOS | Grant | Stock Option (right to buy) | 50k | $2.90 | $145k | | 05/14/2021 |
| 03/25/2021 | BioXcel Therapeutics, Inc. | BTAI | Grant | Stock Option (Right to Buy) | 20k | $41.17 | $823.4k | | 03/25/2021 |
| 02/01/2021 | BioXcel Therapeutics, Inc. | BTAI | Exercise | Stock Option | 3.8k | $5.55 | $20.8k | | 02/01/2021 |
| 02/01/2021 | BioXcel Therapeutics, Inc. | BTAI | Sale | Common Stock | 3.8k | $48.15 | $180.6k | | 02/01/2021 |
| 08/12/2020 | Actinium Pharmaceuticals, Inc. | ATNM | Grant | Stock Option (Right to Buy) | 8.3k | $0.00 | $0 | | 08/12/2020 |
| 05/26/2020 | BioXcel Therapeutics, Inc. | BTAI | Grant | Employee Stock Option (right to buy) | 55k | $45.99 | $2.5M | | 05/26/2020 |
| 05/15/2020 | ATOSSA THERAPEUTICS, INC. | ATOS | Grant | Stock Option (right to buy) | 45k | $1.70 | $76.5k | | 05/15/2020 |
| 07/12/2019 | Actinium Pharmaceuticals, Inc. | ATNM | Grant | Options to purchase common stock | 250k | $0.23 | $58k | | 07/12/2019 |
| 05/17/2019 | ATOSSA THERAPEUTICS, INC. | ATOS | Grant | Stock Option (right to buy) | 45k | $2.52 | $113.4k | | 05/17/2019 |
| 12/03/2018 | BioXcel Therapeutics, Inc. | BTAI | Purchase | Common Stock | 500 | $5.20 | $2.6k | | 12/03/2018 |
| 11/30/2018 | BioXcel Therapeutics, Inc. | BTAI | Purchase | Common Stock | 500 | $5.00 | $2.5k | | 11/30/2018 |
| 11/29/2018 | BioXcel Therapeutics, Inc. | BTAI | Purchase | Common Stock | 500 | $5.00 | $2.5k | | 11/29/2018 |
| 07/13/2018 | Actinium Pharmaceuticals, Inc. | ATNM | Grant | Options to purchase common stock | 75k | $0.78 | $58.7k | | 07/13/2018 |
| 06/27/2018 | ATOSSA THERAPEUTICS, INC. | ATOS | Grant | Stock Option (right to buy) | 45k | $2.38 | $107.1k | | 06/27/2018 |
| 03/12/2018 | BioXcel Therapeutics, Inc. | BTAI | Grant | Stock Options | 32.2k | $11.00 | $354.6k | | 03/12/2018 |
| 03/06/2018 | Actinium Pharmaceuticals, Inc. | ATNM | Other (acquisition) | Common Stock | 7k | $0.50 | $3.5k | | 03/06/2018 |
| 03/06/2018 | Actinium Pharmaceuticals, Inc. | ATNM | Other (acquisition) | Series A Warrants | 1.8k | $0.60 | $1k | | 03/06/2018 |
| 03/06/2018 | Actinium Pharmaceuticals, Inc. | ATNM | Other (acquisition) | Series B Warrants | 5.2k | $0.70 | $3.7k | | 03/06/2018 |
| 05/24/2017 | ATOSSA THERAPEUTICS, INC. | ATOS | Grant | Stock Option (right to buy) | 49.5k | $0.47 | $23.3k | | 05/24/2017 |
| 03/14/2017 | Actinium Pharmaceuticals, Inc. | ATNM | Grant | Options to purchase common stock | 75k | $1.39 | $104.2k | | 03/14/2017 |
| 05/18/2016 | ATOSSA THERAPEUTICS, INC. | ATOS | Grant | Stock Option (right to buy) | 71.5k | $0.26 | $18.8k | | 05/18/2016 |
|